Proleukin and Eczema - a phase IV clinical study of FDA data

Summary:

Eczema is reported only by a few people who take Proleukin.

The phase IV clinical study analyzes which people take Proleukin and have Eczema. It is created by eHealthMe based on reports of 1,826 people who have side effects while taking Proleukin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

1,826 people reported to have side effects when taking Proleukin.
Among them, 4 people (0.22%) have Eczema.

What is Proleukin?

Proleukin has active ingredients of aldesleukin. eHealthMe is studying from 1,829 Proleukin users for its effectiveness, alternative drugs and more.

What is Eczema?

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters) is found to be associated with 2,571 drugs and 1,839 conditions by eHealthMe.

Number of Proleukin and Eczema reports submitted per year:

Time on Proleukin when people have Eczema *:

Gender of people who have Eczema when taking Proleukin *:

female: 0.0 %
male: 100 %

Age of people who have Eczema when taking Proleukin *:

Common drugs people take besides Proleukin *:

Ziagen: 2 people, 50.00%
Norvir: 2 people, 50.00%

Common side effects people have besides Eczema *:

Prurigo (chronic skin disease causing severe itching): 2 people, 50.00%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 50.00%
Malignant Neoplasm Progression (cancer tumour came back): 2 people, 50.00%
Excoriation (to tear or wear off the skin of): 2 people, 50.00%
Chills (felling of cold): 2 people, 50.00%
Viral Load Increased: 1 person, 25.00%
Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 1 person, 25.00%
Skin Hyperpigmentation (disorders affect the colour of your skin): 1 person, 25.00%
Scab (a hard coating on the skin formed during the wound healing): 1 person, 25.00%
Rashes (redness): 1 person, 25.00%

Common conditions people have *:

Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 50.00%
Hiv Infection: 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Proleukin and have Eczema?

Check whether Eczema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Eczema and when was it recovered:

Eczema in Proleukin

Expand to all the drugs that have ingredients of aldesleukin:

Eczema and drugs with ingredients of aldesleukin (4 reports)

Alternative drugs to, pros and cons of Proleukin:

Proleukin (1,829 reports)

Common Proleukin side effects:

Browse all side effects of Proleukin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Eczema treatments and more:

Eczema (41,112 reports)

COVID vaccines that are related to Eczema:

Common drugs associated with Eczema:

All the drugs that are associated with Eczema:

Eczema (2,571 drugs)

Common conditions associated with Eczema:

All the conditions that are associated with Eczema:

Eczema (1,839 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aldesleukin (the active ingredients of Proleukin) and Proleukin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.